Hopman Mark
Chief Commercial Officer
1 company
Insider Signal Score
57
GoodTrades Analyzed
5
12M Win Rate
100.0%
Avg 3M Return
-45.6%
Avg 12M Return
+31.6%
Hopman Mark serves as a Chief Commercial Officer at BBNX. Across recent SEC filings that breaks down to 0 buys and 8 sells. Those positions are worth an estimated $2.3M at current prices.
Historically, Hopman Mark's trades have earned a middling insider score of 57/100 across 5 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +31.6%.
The biggest single holding is BBNX (~$2.3M) as Chief Commercial Officer. The recent filings there lean toward selling, a net 36,378 shares.
Holdings by Company
BBNXJun 4, 2026
Current Shares130.6K
Value$2.30M
Net Activity-36,378
Bought: 0Sold: 36.4K
Transaction History
Showing 5 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | BBNX Beta Bionics, Inc. | Chief Commercial Officer | Sell | 275 | $12.31 | $3,385.25 | -0.2% | - | - | |
| Sep 5, 2025 | BBNX Beta Bionics, Inc. | Chief Commercial Officer | Sale+OE | 18,229 | $20.34 | $370,836.95 | -22.6% | +48.5% | - | |
| Sep 2, 2025 | BBNX Beta Bionics, Inc. | Chief Commercial Officer | Sell | 848 | $18.86 | $15,995.99 | -2.5% | +55.3% | - | |
| Aug 19, 2025 | BBNX Beta Bionics, Inc. | Chief Commercial Officer | Sale+OE | 16,158 | $16.61 | $268,376.30 | -32.1% | +71.0% | - | |
| Jun 2, 2025 | BBNX Beta Bionics, Inc. | Chief Commercial Officer | Sell | 868 | $17.89 | $15,529.30 | -0.8% | +1.8% | -31.6% |